Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".
Grieve
A P
AP
Department of Public Health Sciences, King's College, University of London, London, UK. andy.grieve@kcl.ac.uk
D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D006801:Humans; D012107:Research Design